Showing results (41-50 of 148) with videos related to

Sort By:
Pageof 15
German Journal of Ophthalmology|May 1, 1995
Ophthalmomyiasis externa due to the sheep botfly Oestrus ovis (Diptera: Oestridae) in southwest GermanyJ Grammer, C Erb, G Kamin, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1997
A phase II study of paclitaxel in platinum pretreated ovarian cancer. A Hellenic Cooperative Oncology Group studyG Aravantinos, D V Skarlos, P Kosmidis, et al.
Journal of Pain and Symptom Management|November 1, 1991
Diphenhydramine for nausea and vomiting related to cancer chemotherapy with cisplatinN Tsavaris, N Zamanis, A Zinelis, et al.
Anticancer Research|February 24, 2001
Parameters that influence the outcome of nausea and emesis in cisplatin based chemotherapyN Tsavaris, C Kosmas, N Mylonakis, et al.
The International Journal of Biological Markers|April 1, 1993
Carcinoembryonic antigen (CEA), alpha-fetoprotein, CA 19.9 and CA 125 in advanced colorectal cancer (ACC)N Tsavaris, K Vonorta, H Tsoutsos, et al.
Oncology|July 1, 1995
Efficacy of ondansetron treatment with different timing schedules: a randomized double-blind studyN Tsavaris, N Mylonakis, C Bacoyiannis, et al.
Oncology|September 10, 1998
Combination regimen with carboplatin, epirubicin and etoposide in metastatic carcinomas of unknown primary site: A Hellenic Co-Operative Oncology Group Phase II StudyE Briasoulis, N Tsavaris, G Fountzilas, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1995
Ondansetron versus metoclopramide as antiemetic treatment during cisplatin-based chemotherapy. A prospective study with special regard to regard to electrolyte imbalanceN Tsavaris, G Charalambidis, N Ganas, et al.
Tumori|April 25, 2000
A randomized open-label parallel-group study comparing ondansetron with ondansetron plus dexamethasone in patients with metastatic breast cancer receiving high-dose epirubicin. A Hellenic Cooperative Oncology Group studyJ Janinis, T Giannakakis, A Athanasiades, et al.
American Journal of Clinical Oncology|June 1, 1996
TPA, TATI, CEA, AFP, beta-HCG, PSA, SCC, and CA 19-9 for monitoring transitional cell carcinoma of the bladderD Pectasides, D Bafaloucos, F Antoniou, et al.
Pageof 15